Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine how long the skin lesions usually last and what kind of symptoms and signs children with urticaria pigmentosa may develop over the years. This information will allow physicians to better care for patients who have been diagnosed with this disease and to provide their parents with more complete information regarding what to expect for the future of their child. This research is being done because many unanswered questions remain regarding children with urticaria pigmentosa and its course.


Clinical Trial Description

This study involves children, of age 0-18 years old who are diagnosed with urticaria pigmentosa during their visit at the Pediatric Dermatology Clinic. Parents and child will be interviewed to gain medical and family history, in addition, the doctor will perform a physical exam and take a photograph. Children older than 4 years of age will complete the "Children Dermatology Life Quality Index." Children less than 4 years of age with an active disease will have laboratory tests requiring a sample of blood (1 teaspoon).

Patients will receive $50 for their first office visit as financial reimbursement for participating in the study. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00467792
Study type Observational
Source Medical College of Wisconsin
Contact
Status Completed
Phase N/A
Start date January 2006
Completion date June 2008

See also
  Status Clinical Trial Phase
Completed NCT02761473 - Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
Completed NCT04978740 - Ocular and Palpebral Manifestations of Mastocytosis (MOOMA) N/A